J-113,397

From WikiMD's Medical Encyclopedia

Revision as of 21:26, 25 February 2024 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

J-113,397 is a drug used in scientific research, which acts as a potent and selective antagonist for the nociceptin receptor, also known as the ORL1 receptor. It has analgesic, anti-inflammatory and anxiolytic effects, and reverses the memory impairment produced by agonists at this receptor.

Pharmacology

J-113,397 is a potent and selective antagonist for the nociceptin receptor, also known as the ORL1 receptor. This receptor is a G protein-coupled receptor that is closely related to the classical opioid receptors, but has different effects and distribution in the brain. J-113,397 has been shown to block the effects of nociceptin, the endogenous ligand for the ORL1 receptor, in a variety of animal models.

Effects

J-113,397 has analgesic, anti-inflammatory and anxiolytic effects. It has been shown to reverse the memory impairment produced by agonists at the ORL1 receptor. This suggests that the ORL1 receptor may be involved in the regulation of cognitive processes, and that antagonists at this receptor may have therapeutic potential in the treatment of cognitive disorders.

Research

Research into the effects of J-113,397 and other ORL1 receptor antagonists is ongoing. These drugs have potential for the treatment of a variety of conditions, including pain, inflammation, anxiety and cognitive disorders. However, further research is needed to fully understand the role of the ORL1 receptor in these conditions and the potential benefits and risks of drugs that target this receptor.

See also

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.